Trexquant Investment LP Viking Therapeutics, Inc. Transaction History

Trexquant Investment LP

$8.9 Billion
Q3 2025

A detailed history of Trexquant Investment LP transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 140,531 shares of VKTX stock, worth $5.59 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

140,531

Previous 210,428 33.22%

Holding current value

$5.59 Million

Previous $5.58 Million 35.63%

% of portfolio

0.04%

Previous 0.07%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$23.09 - $42.09 $1.61 Million - $2.94 Million	-69,897 Reduced 33.22%	140,531 $3.59 Million
Q2 2025 Aug 12, 2025	BUY	$19.98 - $29.49 $4.2 Million - $6.21 Million	210,428 New	210,428 $5.58 Million
Q4 2024 Feb 12, 2025	BUY	$38.28 - $78.03 $2.48 Million - $5.06 Million	64,908 New	64,908 $2.61 Million
Q2 2024 Aug 13, 2024	BUY	$47.39 - $80.2 $2.43 Million - $4.11 Million	51,296 New	51,296 $2.72 Million
Q3 2023 Nov 13, 2023	SELL	$10.92 - $16.0 $1.99 Million - $2.91 Million	-182,172 Reduced 68.4%	84,147 $931,000

Q2 2023 Aug 11, 2023	BUY	$14.84 - $24.79 $2.93 Million - $4.89 Million	197,394 Added 286.39%	266,319 $4.32 Million
Q1 2023 May 15, 2023	SELL	$8.08 - $17.33 $335,231 - $719,004	-41,489 Reduced 37.58%	68,925 $1.15 Million
Q4 2022 Feb 13, 2023	BUY	$2.72 - $9.4 $300,326 - $1.04 Million	110,414 New	110,414 $1.04 Million
Q1 2022 May 13, 2022	SELL	$3.0 - $4.88 $56,142 - $91,324	-18,714 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.6 - $6.72 $386 - $564	84 Added 0.45%	18,714 $86,000
Q3 2021 Nov 12, 2021	SELL	$5.58 - $7.04 $14,904 - $18,803	-2,671 Reduced 12.54%	18,630 $117,000
Q2 2021 Aug 12, 2021	BUY	$5.19 - $6.73 $110,552 - $143,355	21,301 New	21,301 $128,000
Q1 2021 May 13, 2021	SELL	$5.74 - $9.67 $113,198 - $190,702	-19,721 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$5.3 - $6.71 $221,020 - $279,820	-41,702 Reduced 67.89%	19,721 $111,000
Q3 2020 Nov 06, 2020	BUY	$5.73 - $8.11 $351,953 - $498,140	61,423 New	61,423 $357,000
Q2 2018 Aug 07, 2018	SELL	$3.88 - $12.74 $249,922 - $820,621	-64,413 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$4.11 - $6.93 $264,737 - $446,382	64,413 New	64,413 $281,000

Others Institutions Holding VKTX

# of Institutions

435

Shares Held

66.6M

Call Options Held

7.21M

Put Options Held

3.87M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.05B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Viking Therapeutics, Inc. Transaction History